StonvexLoading…
StonvexStonvexStonvexCore line items from VTR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.66B | $5.83B | $4.27B | $2.78B |
Operating Income | $35.41M | $204.32M | $128.03M | $83.60M |
Net Income | $59.05M | $261.52M | $188.53M | $119.82M |
EPS (Diluted) | $0.11 | $0.54 | $0.40 | $0.25 |
Total Assets | $27.69B | $27.59B | $26.93B | $26.47B |
Total Liabilities | $14.11B | $14.63B | $14.15B | $14.55B |
Cash & Equivalents | $183.61M | $741.07M | $188.62M | $614.20M |
Free Cash Flow OCF − CapEx | Not available | $-1.28B | Not available | Not available |
Shares Outstanding | 486.10M | 474.93M | 469.45M | 454.25M |